Literature DB >> 22608109

Low maternal hemoglobin during pregnancy and diminished neuromotor and neurocognitive performance in offspring with schizophrenia.

Lauren M Ellman1, Sophia Vinogradov, William S Kremen, John H Poole, David M Kern, Raymond F Deicken, Alan S Brown.   

Abstract

OBJECTIVE: Previous research has linked maternal anemia during pregnancy with increased risk for schizophrenia in offspring. However, no study has sought to determine whether this early insult leads to a more severe form of the disorder, characterized by worsened motor and neurocognitive functioning.
METHOD: Subjects were 24 cases diagnosed with schizophrenia and 22 controls from the Developmental Insult and Brain Anomaly in Schizophrenia (DIBS) study. Hemoglobin values were measured throughout pregnancy. Among offspring, psychiatric diagnoses were determined through semi-structured interviews and medical records review and comprehensive neurocognitive assessment batteries were conducted in adulthood.
RESULTS: Results indicated that among cases decreases in maternal hemoglobin led to significant decreases in scores on the Grooved Pegboard test, the Finger Tapping test and the Wechsler Adult Intelligent Scales (WAIS) information subtest. In contrast, controls only exhibited decreases in performance on the California Verbal Learning Test (CVLT) long-delay recall after fetal exposure to lower hemoglobin. There were also significant interactions between hemoglobin and case status for all of the motor tasks.
CONCLUSIONS: These findings support the hypothesis that fetal exposure to decreases in maternal hemoglobin is related to preferentially poorer neuromotor function among cases compared to controls, as well as general intellectual difficulties among cases. Controls were relatively unaffected by decreased maternal hemoglobin, which suggests that liability to schizophrenia renders cases susceptible to the deleterious influences of in utero exposure to decreases in maternal hemoglobin.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22608109      PMCID: PMC3592571          DOI: 10.1016/j.schres.2012.04.008

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  38 in total

1.  Obstetric complications and schizophrenia: historical and meta-analytic review.

Authors:  Mary Cannon; Peter B Jones; Robin M Murray
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

Review 2.  Is There a Causal Relationship between Iron Deficiency or Iron-Deficiency Anemia and Weight at Birth, Length of Gestation and Perinatal Mortality?

Authors:  K Rasmussen
Journal:  J Nutr       Date:  2001-02       Impact factor: 4.798

3.  Iron deficiency during early development in the rat: behavioral and physiological consequences.

Authors:  J Weinberg; P R Dallman; S Levine
Journal:  Pharmacol Biochem Behav       Date:  1980-04       Impact factor: 3.533

4.  Childhood neuromotor dysfunction in schizophrenia patients and their unaffected siblings: a prospective cohort study.

Authors:  I M Rosso; C E Bearden; J M Hollister; T L Gasperoni; L E Sanchez; T Hadley; T D Cannon
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

5.  Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8.

Authors:  Lauren M Ellman; Raymond F Deicken; Sophia Vinogradov; William S Kremen; John H Poole; David M Kern; Wei Yann Tsai; Catherine A Schaefer; Alan S Brown
Journal:  Schizophr Res       Date:  2010-06-09       Impact factor: 4.939

Review 6.  Schizophrenia and cognitive function.

Authors:  G Kuperberg; S Heckers
Journal:  Curr Opin Neurobiol       Date:  2000-04       Impact factor: 6.627

Review 7.  Iron and oxidative stress in pregnancy.

Authors:  Esther Casanueva; Fernando E Viteri
Journal:  J Nutr       Date:  2003-05       Impact factor: 4.798

8.  Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers.

Authors:  Theo G M Van Erp; Peter A Saleh; Isabelle M Rosso; Matti Huttunen; Jouko Lönnqvist; Tiia Pirkola; Oili Salonen; Leena Valanne; Veli-Pekka Poutanen; Carl-Gustav Standertskjöld-Nordenstam; Tyrone D Cannon
Journal:  Am J Psychiatry       Date:  2002-09       Impact factor: 18.112

9.  Perinatal iron deficiency alters apical dendritic growth in hippocampal CA1 pyramidal neurons.

Authors:  Lyric A Jorgenson; Jane D Wobken; Michael K Georgieff
Journal:  Dev Neurosci       Date:  2003 Nov-Dec       Impact factor: 2.984

10.  Effect of prenatal iron deficiency on myelination in rat pups.

Authors:  G S Yu; T M Steinkirchner; G A Rao; E C Larkin
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

View more
  5 in total

1.  Somatic diseases and conditions before the first diagnosis of schizophrenia: a nationwide population-based cohort study in more than 900 000 individuals.

Authors:  Holger J Sørensen; Philip R Nielsen; Michael E Benros; Carsten B Pedersen; Preben B Mortensen
Journal:  Schizophr Bull       Date:  2014-07-25       Impact factor: 9.306

2.  Sensorimotor and Activity Psychosis-Risk (SMAP-R) Scale: An Exploration of Scale Structure With Replication and Validation.

Authors:  Katherine S F Damme; Jason Schiffman; Lauren M Ellman; Vijay A Mittal
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

Review 3.  Iron Deficiency and Iron Deficiency Anemia: Implications and Impact in Pregnancy, Fetal Development, and Early Childhood Parameters.

Authors:  Robert T Means
Journal:  Nutrients       Date:  2020-02-11       Impact factor: 5.717

4.  Perinatal complications and executive dysfunction in early-onset schizophrenia.

Authors:  Charlotte M Teigset; Christine Mohn; Bjørn Rishovd Rund
Journal:  BMC Psychiatry       Date:  2020-03-04       Impact factor: 3.630

5.  Review of Standard Laboratory Blood Parameters in Patients with Schizophrenia and Bipolar Disorder.

Authors:  Amra Memic-Serdarevic; Lejla Burnazovic-Ristic; Gorana Sulejmanpasic; Amir Tahirovic; Amina Valjevac; Edina Lazovic
Journal:  Med Arch       Date:  2020-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.